LV12000B - Olbaltumviela ar urātoksidāzes aktivitāti un tās iegūšana - Google Patents

Olbaltumviela ar urātoksidāzes aktivitāti un tās iegūšana Download PDF

Info

Publication number
LV12000B
LV12000B LVP-97-200A LV970200A LV12000B LV 12000 B LV12000 B LV 12000B LV 970200 A LV970200 A LV 970200A LV 12000 B LV12000 B LV 12000B
Authority
LV
Latvia
Prior art keywords
thr
lys
ser
leu
glu
Prior art date
Application number
LVP-97-200A
Other languages
English (en)
Latvian (lv)
Other versions
LV12000A (lv
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elizabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Application filed by Sanofi filed Critical Sanofi
Publication of LV12000A publication Critical patent/LV12000A/xx
Publication of LV12000B publication Critical patent/LV12000B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
LVP-97-200A 1989-07-13 1997-10-15 Olbaltumviela ar urātoksidāzes aktivitāti un tās iegūšana LV12000B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.

Publications (2)

Publication Number Publication Date
LV12000A LV12000A (lv) 1998-03-20
LV12000B true LV12000B (lv) 1998-06-20

Family

ID=27251947

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-200A LV12000B (lv) 1989-07-13 1997-10-15 Olbaltumviela ar urātoksidāzes aktivitāti un tās iegūšana

Country Status (24)

Country Link
EP (1) EP0408461B1 (de)
JP (1) JP2664804B2 (de)
AT (1) ATE144282T1 (de)
AU (1) AU636637B2 (de)
BR (1) BR9006855A (de)
CA (1) CA2035900C (de)
DE (2) DE10199042I2 (de)
DK (1) DK0408461T3 (de)
ES (1) ES2095243T3 (de)
FI (1) FI105047B (de)
GR (1) GR3022085T3 (de)
HK (1) HK1000099A1 (de)
HU (1) HU215948B (de)
IE (1) IE77158B1 (de)
IL (1) IL95057A (de)
LU (1) LU90781I2 (de)
LV (1) LV12000B (de)
MC (1) MC2145A1 (de)
NL (1) NL300046I2 (de)
NO (1) NO2001018I2 (de)
NZ (1) NZ234453A (de)
PT (1) PT94680B (de)
RU (1) RU2105812C1 (de)
WO (1) WO1991000909A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (ja) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 ウリカーゼ遺伝子およびウリカーゼの製造法
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
HU230275B1 (hu) * 1996-09-13 2015-11-30 Shire Human Genetic Therapies, Inc Eljárás tisztított humán alfa-galaktozidáz-A készítmények előállítására, és a tisztított készítményeket tartalmazó gyógyászati készítmények, alfa-gal-A-deficienciából eredő rendellenességek kezelésében történő alkalmazásra
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
CN1275980C (zh) 2000-08-17 2006-09-20 味之素株式会社 来源于微生物的转谷氨酰胺酶的修饰方法
JP5570677B2 (ja) 2002-04-25 2014-08-13 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド α−ガラクトシダーゼＡ欠損症の治療
WO2006110819A2 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
SG10201706384VA (en) 2005-04-11 2017-09-28 Crealta Pharmaceuticals Llc A variant form of urate oxidase and use thereof
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
RU2443426C2 (ru) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Конъюгаты уратоксидазы, фармацевтическая композиция для снижения уровней мочевой кислоты и способ получения вышеупомянутых конъюгатов
BRPI1010069A2 (pt) 2009-06-25 2016-03-15 Savient Pharmaceuticals Inc "método para prevenir reações à infusão durante terapia por uricase peguilada em pacientes; e método para diagnosticar se um paciente tratado com uricase peguilada desenvolverá reações à infusão ou desenvolverá liberação de uricase peguilada mediada por anticorpo sem a medição de títulos de anticorpos anti-peg e anti-uricase peguilada"
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529675A (fr) * 1967-03-29 1968-06-21 Applic Biochimiques Soc Et Urate oxydase à haute activité et sa préparation
SU457723A1 (ru) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Штамм 313-152 - продуцент уратоксидазы
EP0423890A3 (en) * 1984-07-27 1991-07-03 Unilever Nv Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (ja) * 1988-08-17 1994-09-14 サッポロビール株式会社 ウリカーゼのｄｎａ配列および製法

Also Published As

Publication number Publication date
HUT56884A (en) 1991-10-28
CA2035900C (fr) 2000-01-11
LV12000A (lv) 1998-03-20
FI105047B (fi) 2000-05-31
DE10199042I2 (de) 2003-10-23
NZ234453A (en) 1993-01-27
PT94680B (pt) 1997-04-30
NO2001018I2 (no) 2006-05-01
RU2105812C1 (ru) 1998-02-27
HU906046D0 (en) 1991-07-29
DE69028884T2 (de) 1997-05-07
PT94680A (pt) 1991-04-18
AU636637B2 (en) 1993-05-06
GR3022085T3 (en) 1997-03-31
JPH04501807A (ja) 1992-04-02
IL95057A0 (en) 1991-06-10
JP2664804B2 (ja) 1997-10-22
IL95057A (en) 1997-07-13
DK0408461T3 (da) 1997-03-24
ATE144282T1 (de) 1996-11-15
HK1000099A1 (en) 1997-11-21
EP0408461A1 (de) 1991-01-16
WO1991000909A1 (fr) 1991-01-24
CA2035900A1 (fr) 1991-01-14
HU215948B (hu) 1999-03-29
DE10199042I1 (de) 2002-01-10
IE77158B1 (en) 1997-12-03
NL300046I2 (nl) 2001-12-01
NL300046I1 (nl) 2001-09-03
MC2145A1 (fr) 1992-02-18
DE69028884D1 (de) 1996-11-21
IE902559A1 (en) 1991-02-27
EP0408461B1 (de) 1996-10-16
AU6052390A (en) 1991-02-06
FI911212A0 (fi) 1991-03-12
BR9006855A (pt) 1991-08-06
ES2095243T3 (es) 1997-02-16
LU90781I2 (fr) 2001-07-23

Similar Documents

Publication Publication Date Title
LV12000B (lv) Olbaltumviela ar urātoksidāzes aktivitāti un tās iegūšana
EP0293357B1 (de) Expression von menschlichem Proapolipoprotein A-1
Palfree et al. Yeast killer toxin: purification and characterisation of the protein toxin from Saccharomyces cerevisiae
KR0159107B1 (ko) 우레이트 산화효소 활성 단백질, 이 단백질을 암호화하는 재조합 유전자, 발현 벡터, 미생물 및 형질전환세포
EP0236210B1 (de) Verfahren zur Herstellung von reifem, menschlichem Serum-Albumin
JPH1129598A (ja) 精製した毛様体神経栄養因子
Lugtenberg et al. Pore protein e of the outer membrane of Escherichia coli K12
JPH09512423A (ja) エラスターゼ阻害活性を有するα−１−アンチキモトリプシンアナログ
JPS6193128A (ja) 遺伝子工学で処理した微生物から精製成長ホルモンを回収する方法
EP0402205A1 (de) Verfahren zur Herstellung von gereinigten Albuminlösungen
EP0198745B1 (de) Verfahren zur mikrobiologischen Herstellung von menschlichem Serum-Albumin
Varga et al. Pigment-protein complexes from Rhodopseudomonas palustris: isolation, characterization, and reconstitution into liposomes
JP4372421B2 (ja) 細胞からタンパク質を抽出するための方法および組成物
Lehman et al. Large-scale purification and characterization of recombinant tick anticoagulant peptide
Keen The structure of clathrin-coated membranes: assembly and disassembly
CN1055009A (zh) 人的碱性fgf突变蛋白质的制备
RU2337966C2 (ru) Препарат рекомбинантного человеческого сывороточного альбумина и способ его получения
CN1152337A (zh) 超氧化物歧化酶-4
JP3004788B2 (ja) アルギニンデイミナーゼ発現ベクター、形質転換微生物およびアルギニンデイミナーゼの製造法
EP0435776A1 (de) Künstlicher Promoter zur Proteine Expression in Hefe
EP0475842B1 (de) Expressionskassette eines Vorläufers von Endothiapepsine in Cryphonectria parasitica
Maezawa et al. Determination of the regions of the clathrin molecule inducing membrane fusion
FR2667612A1 (fr) Production stable de polypeptide actif m-csf.
JPH07289267A (ja) 発現増強方法
JPH04117284A (ja) ジヒドロ葉酸還元酵素―抗アレルギー性ペンタペプチド融合タンパク質